In particular, EPC1 has been reported to sustain the oncogenic potential of the leukemic stem cells in MLL-rearranged acute myeloid leukemia [39] and SET2D has been recently implicated in safeguarding the genomic integrity of MLL-rearranged leukemias [40]. Here, KMT2A is linked to leukemia.